Sapio HealthSapio Health
  • Today
  • Patients
  • Inbox
  • Calendar
Insight
  • Population
  • Quality (QOF)
System
  • Models
  • Data feeds
  • Settings
Practice trajectory
-26%
JD
Dr John Dolittle
Ashford Vale Medical Group
Patients/Margaret Chen · SH-10284
← Practice Horizon

Margaret Chen

67F · SH-10284APP
Metabolic-Renal · Retired (librarian)
Next consult
Fri 17 Apr, 09:30
Positive· p 0.84Trending worse
Trajectory headline
Projected to cross cardiorenal decompensation threshold within 3y without SGLT2 initiation.
Model priority
Positive zone
Biggest single change you could makeAdd GLP-1 → −98% (HbA1c)
AIME · trajectory-grounded

Drafted communications

Multi-LLM ensemble weighted by current physiological state — review before sending.

Patient letterKidney function update — action needed
To · Margaret Chen
Grounding
92%
Dear Mrs Chen,

Following your recent blood tests, I wanted to share where we are and what I'd like to do about it. Your kidney function has been slowly declining over the past year and a small amount of protein is showing up in your urine. On its own this isn't an emergency, but together with your diabetes and blood pressure it is a pattern we want to turn around now rather than later.

I'd like to start you on a medication called empagliflozin. It's a diabetes tablet that, importantly, also protects the kidneys and the heart in people with exactly the pattern you have. You'll come in for a short appointment to discuss this and we'll arrange a repeat urine test to confirm the finding.

Nothing needs to change today. I'll see you on Friday.

Kind regards,
Dr Dolittle
Grounded on: eGFR · UACR · HbA1c / cardiorenal + metabolic
ReferralNephrology — early CKD with albuminuria
To · Renal Clinic, SMH
Grounding
88%
67F with T2DM (11y), HTN, and progressive CKD. eGFR 48 (from 54 in 10m), UACR 38 mg/g on single measurement (repeat pending). Horizon-1 trajectory: cardiorenal syndrome activation 0.81, projected decompensation window 3y without SGLT2 initiation. Referring for shared co-management prior to introducing SGLT2 and confirming no additional pathology. Happy to initiate empagliflozin in primary care if preferred.
Grounded on: eGFR · UACR · SBP / cardiorenal
For demonstration purposes. Not a diagnostic tool.